| Justin B Herman, | |
|
2608 Keiser Blvd, Wyomissing, PA 19610-3333 | |
| (610) 685-5864 | |
| (610) 929-1528 |
| Full Name | Justin B Herman |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Pulmonary Disease |
| Location | 2608 Keiser Blvd, Wyomissing, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134462351 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0200X | Internal Medicine - Critical Care Medicine | MD457095 (Pennsylvania) | Secondary |
| 207RP1001X | Internal Medicine - Pulmonary Disease | MD457095 (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Justin B Herman, 2608 Keiser Blvd, Wyomissing, PA 19610-3333 Ph: (610) 685-5864 | Justin B Herman, 2608 Keiser Blvd, Wyomissing, PA 19610-3333 Ph: (610) 685-5864 |
News Archive
Berlin Heart Inc. reported today that it has completed enrollment in Cohort 1 of the Berlin Heart EXCOR(R) Pediatric IDE Study after having received unconditional approval of the study from the FDA in November 2008.
It's all fun in the sun until you realize you should have reapplied more sunscreen. Sunburns are no fun, but more importantly, they are dangerous. This reddening of your skin caused by overexposure to the sun's ultraviolet (UV) radiation may seem like just a temporary irritation- but it can cause long-lasting damage.
RainDance Technologies, Inc., the Digital Biology Company, today announced that the University College London (UCL) Cancer Institute has adopted its ThunderStorm System as a centralized platform for the validation of genomic and epigenomic targets from clinical and non-clinical studies, including follow-ups for genome-wide and epigenome-wide association studies (GWAS and EWAS), as well as stratified cancer medicine and basic research.
BioCryst Pharmaceuticals, Inc. announced favorable 52-week safety results and sustained efficacy from the extension phase of its randomized Phase 2b trial of ulodesine (BCX4208) added to allopurinol in patients with gout who had failed to reach the serum uric acid (sUA) therapeutic goal of <6 mg/dL on allopurinol alone, as well as positive Phase 2 safety results in patients with mild to moderate renal impairment.
› Verified 1 days ago
Nirav R. Shah, MD, MPH Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1011 Reed Ave, Suite 300, Wyomissing, PA 19610 Phone: 610-374-4401 Fax: 610-374-7140 | |
Dr. David F Steffy, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 950b N Wyomissing Blvd, 3rd Floor, Wyomissing, PA 19610 Phone: 610-898-1820 Fax: 610-372-0164 | |
Dr. Michael Bernard Russo, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2605 Keiser Blvd, Wyomissing, PA 19610 Phone: 610-685-8500 Fax: 610-685-4833 | |
Dr. Pallak Agarwal, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2608 Keiser Blvd, Wyomissing, PA 19610 Phone: 610-685-5864 Fax: 610-929-1528 | |
Dr. Kristie Marie Pepper, D.O. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2760 Century Blvd, Wyomissing, PA 19610 Phone: 610-375-4251 Fax: 610-685-2870 | |
Louis La Luna, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1011 Reed Ave, Suite 300, Wyomissing, PA 19610 Phone: 610-374-4401 Fax: 610-374-7140 | |
Tara Lynn Dimino, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 2605 Keiser Blvd, Wyomissing, PA 19610 Phone: 610-685-8500 Fax: 610-685-4833 |